Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Ítems similars

• Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
  per: Kobayashi, Haruki, et al.
  Publicat: (2018)
• Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy
  per: Nakashima, Kazuhisa, et al.
  Publicat: (2016)
• Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
  per: Mamesaya, Nobuaki, et al.
  Publicat: (2018)
• Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy
  per: Miyawaki, Taichi, et al.
  Publicat: (2020)
• Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer
  per: WAKUDA, KAZUSHIGE, et al.
  Publicat: (2019)